Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”

Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”

Saved in:

Bibliographic Details
Main Authors:	Patrick Cherin, Jean-Christophe Delain, Jean-Charles Crave, Odile Cartry
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Case Reports in Rheumatology
Online Access:	http://dx.doi.org/10.1155/2015/436736
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortage
by: Pedro Moral Moral, et al.
Published: (2025-01-01)

Severe Periodontal Disease Associated with Long-Term Treatment with Intravenous Immunoglobulin
by: Jôice Dias Corrêa, et al.
Published: (2014-01-01)

Is polymyositis a rare or over-diagnosed entity? A descriptive follow-up study of patients initially admitted in a tertiary center with the diagnosis of polymyositis
by: Pablo Arturo Olivo Pallo, et al.
Published: (2020-01-01)

Lymphomatoid Granulomatosis with Paraneoplastic Polymyositis: A Rare Malignancy with Rare Complication
by: Shanley O’Brien, et al.
Published: (2016-01-01)

Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial.
by: Westyn Branch-Elliman, et al.
Published: (2022-01-01)

Polymyositis-Dermatomyositis and Interstitial Lung Disease in Pregnant Woman Successfully Treated with Cyclosporine and Tapered Steroid Therapy
by: Saito Mayu, et al.
Published: (2019-01-01)

New Onset of Dermatomyositis/Polymyositis during Anti-TNF-α Therapies: A Systematic Literature Review
by: Alexandra Maria Giovanna Brunasso, et al.
Published: (2014-01-01)

Combination of High-Dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic Neuritis
by: Andrew W. Campbell, et al.
Published: (2003-01-01)

Corrigendum to “Fully Covered Metallic Stents for the Treatment of Benign Airway Stenosis”
by: Caroline Dahlqvist, et al.
Published: (2018-01-01)

Role of Subcutaneous Adipose Tissue in the Pathogenesis of Insulin Resistance
by: Pavankumar Patel, et al.
Published: (2013-01-01)

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
by: R. Rodríguez-Lojo, et al.
Published: (2010-01-01)

Successful Nonsurgical Treatment of Pneumomediastinum, Pneumothorax, Pneumoperitoneum, Pneumoretroperitoneum, and Subcutaneous Emphysema following ERCP
by: L. Fujii, et al.
Published: (2010-01-01)

Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE)
by: Diana Straubel, et al.
Published: (2018-01-01)

Augmentation of Antipsychotic Medications with Low-Dose Clozapine in Treatment-Resistant Schizophrenia—Case Reports and Discussion
by: Zoe Harrison, et al.
Published: (2021-01-01)

Successful treatment of etanercept- and adalimumab-resistant pyoderma gangrenosum with spesolimab, moderate-dose corticosteroids, and minocycline
by: Hanlin Zhang, et al.
Published: (2025-12-01)

Corrigendum to “Development of New Tools to Detect Colistin-Resistance among Enterobacteriaceae Strains”
by: Lucie Bardet, et al.
Published: (2019-01-01)

Severe subcutaneous infection with Clostridium septicum in a herd of native Icelandic horses
by: Charlotta Oddsdóttir, et al.
Published: (2025-02-01)

Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature
by: Eric Wierda, et al.
Published: (2020-06-01)

ImmunoglobuliN in the Treatment of Encephalitis (IgNiTE): protocol for a multicentre randomised controlled trial
by: R Kneen, et al.
Published: (2016-11-01)

Sweet Syndrome due to Myelodysplastic Syndrome: Possible Therapeutic Role of Intravenous Immunoglobulin in Addition to Standard Treatment
by: Harry H. S. Gill, et al.
Published: (2010-01-01)

The Influence of MHC and Immunoglobulins A and E on Host Resistance to Gastrointestinal Nematodes in Sheep
by: C. Y. Lee, et al.
Published: (2011-01-01)

Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf Countries
by: Anas Hamad, et al.
Published: (2024-07-01)

Total Parathyroidectomy with Subcutaneous Parathyroid Forearm Autotransplantation in the Treatment of Secondary Hyperparathyroidism: A Single-Center Experience
by: Claudio Casella, et al.
Published: (2018-01-01)

Dramatic Improvement of Subcutaneous Calcinosis by Intermittent, High-Dose Etidronate plus Cimetidine in a Patient with Juvenile Dermatomyositis
by: Takayuki Wakabayashi, et al.
Published: (2015-01-01)

Use of Multiple Doses of Intravenous Infusion of Umbilical Cord-Mesenchymal Stem Cells for the Treatment of Adult Patients with Severe COVID-19-Related Acute Respiratory Distress Syndrome: Literature Review
by: Po-Ren Hsueh, et al.
Published: (2023-01-01)

Radiopharmacokinetic modelling and radiation dose assessment of 223Ra used for treatment of metastatic castration-resistant prostate cancer
by: Vera Höllriegl, et al.
Published: (2021-06-01)

A Case Report of Steroid-Resistant Cryptogenic Organizing Pneumonia Managed with Intravenous Immunoglobulins
by: Christian Akem Dimala, et al.
Published: (2021-01-01)

Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis
by: Toru Arai, et al.
Published: (2022-01-01)

Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease
by: Mei-Chen Ou-Yang, et al.
Published: (2013-01-01)

A model of optimal dosing of antibiotic treatment in biofilm
by: Mudassar Imran, et al.
Published: (2013-12-01)

Glucocorticosteroid in Treatment of Severe Pneumonia
by: Felinda Ariani, et al.
Published: (2013-01-01)

Subcutaneous Leiomyosarcoma of the Frenulum
by: D. Mendis, et al.
Published: (2005-01-01)

Severe Hypotension, Hypoxia, and Subcutaneous Erythema Induced by Indigo Carmine Administration during Open Prostatectomy
by: Koichiro Nandate, et al.
Published: (2016-01-01)

Prevention of Elevation in Plasma Triacylglycerol with High-Dose Bezafibrate Treatment Abolishes Insulin Resistance and Attenuates Glucose Intolerance Induced by Short-Term Treatment with Dexamethasone in Rats
by: Maiara Destro Inácio, et al.
Published: (2018-01-01)

Correction: Radiopharmacokinetic modelling and radiation dose assessment of 223Ra used for treatment of metastatic castration-resistant prostate cancer
by: Vera Höllriegl, et al.
Published: (2025-01-01)

Corrigendum: IL-18 biology in severe asthma
by: Sarita Thawanaphong, et al.
Published: (2025-01-01)

Changes in Serum Immunoglobulin Levels Play as Predictors of Treatment Response and Prognosis in Pediatric Idiopathic Nephrotic Syndrome During the Remission Phase
by: Amin sadat Sharif, et al.
Published: (2025-01-01)

Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
by: Vasilios Papademetriou, et al.
Published: (2011-01-01)

The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
by: Piotr Kędzierski, et al.
Published: (2025-01-01)

An unusual case of itchy subcutaneous nodules secondary to aluminium allergy from vaccination
by: Nicholas Ann Hong Teo, et al.
Published: (2024-01-01)